Elise N. Everett
University of Virginia Health System
15 Papers
188 Citations
Elise N. Everett is an academic researcher from University of Virginia Health System. The author has contributed to research in topics: Medicine & Endometrial cancer. The author has an hindex of 9, co-authored 9 publications. Previous affiliations of Elise N. Everett include University of Washington & University of Virginia.
Chat about Author
Papers
The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer
Jason A. Lachance,Elise N. Everett,Benjamin E. Greer,Lynn S. Mandel,Elizabeth M. Swisher,Hisham K. Tamimi,Barbara A. Goff +6 more
TL;DR: Younger patients with endometrial cancer are generally more obese, with lower grade, lower stage disease, and with more favorable histologic cell types, compared to older patients, which should be a consideration in appropriate referrals to gynecologic oncologists.
130
Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases
Pamela J. Paley,Dan S. Veljovich,Chirag A. Shah,Elise N. Everett,Amy E. Bondurant,Charles W. Drescher,William A. Peters +6 more
TL;DR: RS is associated with favorable morbidity and conversion rates in an unselected cohort and compared to laparotomy, robotic ECS results in improved outcomes.
106
Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
Elise N. Everett,Amy E. French,Rebecca L. Stone,Lisa M. Pastore,Amir A. Jazaeri,Willie A. Andersen,Peyton T. Taylor +6 more
TL;DR: Initial chemotherapy is a reasonable alternative to initial surgery for the treatment of selected patients with advanced epithelial ovarian cancer.
61
Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer
Chirag A. Shah,E. Blair Johnson,Elise N. Everett,Hisham K. Tamimi,Benjamin E. Greer,Elizabeth M. Swisher,Barbara A. Goff +6 more
TL;DR: Tumor size correlates with extrauterine disease, but it is not an independent prognostic variable, and the risk of nodal metastases remains even for those patients with very small tumors, underscoring the need for routine complete surgical staging.
60
Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer.
Elise N. Everett,Cara Heuser,Lisa M. Pastore,Willie A. Anderson,Laurel W. Rice,William P. Irvin,Peyton T. Taylor +6 more
TL;DR: A suboptimal cytoreduction confers no survival advantage to women with advanced ovarian cancer, and these patients may be the best candidates for initial chemotherapy, and identifying them preoperatively becomes important.
33